ARTICLE | Company News
OrthoLogic extends license to Chrysalin
July 20, 2000 7:00 AM UTC
OLGC extended its license agreement with Chrysalis BioTechnology (Galveston, Texas) for Chrysalin, a synthetic 23-amino acid thrombin mimic for tissue repair. Previously, OLGC had licensed rights to C...